Eps Summary of RegeneRx Biopharmaceuticals, Inc.

RegeneRx Biopharmaceuticals, Inc.'s latest annual eps in 2022 was -0.01 USD , up 13.67% from previous year.
RegeneRx Biopharmaceuticals, Inc.'s latest quarterly eps in 2023 Q3 was - USD , down 0.0% from previous quarter.
RegeneRx Biopharmaceuticals, Inc. reported an annual eps of -0.01 USD in 2021, down -6.11% from previous year.
RegeneRx Biopharmaceuticals, Inc. reported an annual eps of -0.01 USD in 2020, down -10.08% from previous year.
RegeneRx Biopharmaceuticals, Inc. reported a quarterly eps of - USD for 2023 Q2, up 100.0% from previous quarter.
RegeneRx Biopharmaceuticals, Inc. reported a quarterly eps of - USD for 2023 Q3, down 0.0% from previous quarter.

Annual Eps Chart of RegeneRx Biopharmaceuticals, Inc. (2022 - 1995)

Historical Annual Eps of RegeneRx Biopharmaceuticals, Inc. (2022 - 1995)

Year	Eps	Eps Growth
2022	-0.01 USD	13.67%
2021	-0.01 USD	-6.11%
2020	-0.01 USD	-10.08%
2019	-0.01 USD	27.88%
2018	-0.02 USD	-711.11%
2017	0.00 USD	28.57%
2016	0.00 USD	104.05%
2015	-0.05 USD	-75.93%
2014	-0.03 USD	-259.76%
2013	-0.01 USD	21.15%
2012	-0.01 USD	86.13%
2011	-0.08 USD	-2.18%
2010	-0.07 USD	38.83%
2009	-0.12 USD	42.86%
2008	-0.21 USD	12.5%
2007	-0.24 USD	-14.29%
2006	-0.21 USD	-40.0%
2005	-0.15 USD	-50.0%
2004	-0.10 USD	-71.82%
2003	-0.06 USD	-5.82%
2002	-0.06 USD	-614.29%
2001	-0.01 USD	-113.95%
2000	0.06 USD	192.93%
1999	-0.06 USD	-139.6%
1998	0.15 USD	314.29%
1997	-0.07 USD	61.11%
1996	-0.18 USD	60.87%
1995	-0.46 USD	0.0%

Year	Eps	Eps Growth
2023 Q1	-0.00 USD	-40.74%
2023 Q2	- USD	100.0%
2023 Q3	- USD	0.0%
2022 FY	- USD	13.67%
2022 Q1	-0.00 USD	3.23%
2022 Q2	-0.00 USD	-26.67%
2022 Q3	-0.00 USD	31.58%
2022 Q4	-0.00 USD	-3.85%
2021 Q2	-0.00 USD	10.71%
2021 Q3	-0.00 USD	-20.0%
2021 FY	- USD	-6.11%
2021 Q4	-0.00 USD	-3.33%
2021 Q1	-0.00 USD	0.0%
2020 Q4	-0.00 USD	-12.0%
2020 FY	- USD	-10.08%
2020 Q1	-0.00 USD	-7.41%
2020 Q2	-0.00 USD	-13.79%
2020 Q3	-0.00 USD	24.24%
2019 Q3	-0.00 USD	16.67%
2019 Q2	-0.00 USD	-15.38%
2019 Q1	-0.00 USD	-23.81%
2019 FY	- USD	27.88%
2019 Q4	-0.00 USD	-8.0%
2018 Q2	-0.00 USD	64.77%
2018 Q3	-0.00 USD	0.0%
2018 Q4	-0.00 USD	32.26%
2018 FY	- USD	-711.11%
2018 Q1	-0.01 USD	-169.29%
2017 Q4	0.01 USD	200.0%
2017 Q3	-0.01 USD	-1254.55%
2017 FY	- USD	28.57%
2017 Q1	0.00 USD	-75.0%
2017 Q2	0.00 USD	10.0%
2016 Q3	0.01 USD	-50.0%
2016 Q4	0.00 USD	-60.0%
2016 Q1	-0.03 USD	-410.77%
2016 FY	- USD	104.05%
2016 Q2	0.02 USD	160.24%
2015 FY	- USD	-75.93%
2015 Q4	-0.01 USD	41.44%
2015 Q1	-0.02 USD	-220.75%
2015 Q3	-0.01 USD	36.21%
2015 Q2	-0.02 USD	-2.35%
2014 Q1	-0.03 USD	-25700.0%
2014 Q2	-0.00 USD	90.7%
2014 Q4	-0.01 USD	-507.69%
2014 FY	- USD	-259.76%
2014 Q3	0.00 USD	154.17%
2013 Q3	-0.00 USD	57.14%
2013 Q2	-0.00 USD	31.71%
2013 Q1	-0.00 USD	-241.67%
2013 FY	- USD	21.15%
2013 Q4	-0.00 USD	91.67%
2012 Q2	-0.00 USD	47.17%
2012 Q3	-0.00 USD	57.14%
2012 Q4	-0.00 USD	0.0%
2012 FY	- USD	86.13%
2012 Q1	-0.01 USD	50.0%
2011 Q2	-0.02 USD	4.48%
2011 FY	- USD	-2.18%
2011 Q4	-0.01 USD	57.94%
2011 Q3	-0.03 USD	-31.25%
2011 Q1	-0.02 USD	-73.28%
2010 Q1	-0.02 USD	10.8%
2010 Q2	-0.02 USD	-8.95%
2010 Q3	-0.02 USD	-4.35%
2010 FY	- USD	38.83%
2010 Q4	-0.01 USD	46.3%
2009 Q3	-0.02 USD	15.61%
2009 Q4	-0.02 USD	6.17%
2009 FY	- USD	42.86%
2009 Q2	-0.03 USD	42.64%
2009 Q1	-0.05 USD	12.5%
2008 Q3	-0.05 USD	17.12%
2008 Q4	-0.05 USD	-16.52%
2008 FY	- USD	12.5%
2008 Q2	-0.06 USD	-3.35%
2008 Q1	-0.05 USD	29.43%
2007 Q2	-0.05 USD	15.56%
2007 Q4	-0.08 USD	-70.25%
2007 FY	- USD	-14.29%
2007 Q1	-0.06 USD	-91.45%
2007 Q3	-0.04 USD	18.43%
2006 Q1	-0.03 USD	40.31%
2006 Q2	-0.09 USD	-145.4%
2006 FY	- USD	-40.0%
2006 Q3	-0.05 USD	43.79%
2006 Q4	-0.03 USD	29.38%
2005 Q4	-0.06 USD	-58.86%
2005 FY	- USD	-50.0%
2005 Q1	-0.02 USD	-8.7%
2005 Q2	-0.03 USD	-8.8%
2005 Q3	-0.04 USD	-34.93%
2004 Q4	-0.02 USD	22.56%
2004 Q2	-0.01 USD	69.42%
2004 Q1	-0.04 USD	-112.28%
2004 FY	- USD	-71.82%
2004 Q3	-0.03 USD	-167.57%
2003 Q3	-0.01 USD	26.29%
2003 FY	- USD	-5.82%
2003 Q2	-0.02 USD	-62.04%
2003 Q1	-0.01 USD	38.98%
2003 Q4	-0.02 USD	-32.56%
2002 Q1	-0.01 USD	0.0%
2002 Q3	-0.01 USD	30.34%
2002 FY	- USD	-614.29%
2002 Q2	-0.02 USD	-217.86%
2002 Q4	-0.02 USD	-42.74%
2001 Q1	0.00 USD	136.36%
2001 FY	- USD	-113.95%
2001 Q4	-0.01 USD	-473.33%
2001 Q3	0.00 USD	126.32%
2001 Q2	-0.01 USD	-385.0%
2000 FY	- USD	192.93%
2000 Q1	0.08 USD	1152.63%
2000 Q2	-0.00 USD	-102.63%
2000 Q3	-0.00 USD	-123.81%
2000 Q4	-0.01 USD	-17.02%
1999 Q1	-0.03 USD	0.0%
1999 Q2	-0.02 USD	35.56%
1999 Q3	-0.02 USD	0.0%
1999 Q4	-0.01 USD	62.56%
1999 FY	- USD	-139.6%
1998 FY	- USD	314.29%
1997 FY	- USD	61.11%
1996 FY	- USD	60.87%
1995 FY	- USD	0.0%

Peer Eps Comparison of RegeneRx Biopharmaceuticals, Inc.

Name	Eps	Eps Difference
Evofem Biosciences, Inc.	10.35 USD	100.116%
Neon Bloom, Inc.	-0.00 USD	-700.0%
Nascent Biotech, Inc.	-0.01 USD	10.448%
ProtoKinetix, Incorporated	-0.01 USD	-20.0%
Qrons Inc.	-0.06 USD	79.417%
Rebus Holdings, Inc.	-0.03 USD	62.617%
Skye Bioscience, Inc.	-5.37 USD	99.777%
Santhera Pharmaceuticals Holding AG	5.95 USD	100.202%
Adynxx, Inc.	- USD	Infinity%
Northwest Biotherapeutics, Inc.	-0.06 USD	79.13%
Acro Biomedical Co., Ltd.	-0.26 USD	95.385%
Arch Therapeutics, Inc.	-2.27 USD	99.471%
Burzynski Research Institute, Inc.	-0.01 USD	-17.647%
Eiger BioPharmaceuticals, Inc.	-50.78 USD	99.976%
Nanobac Pharmaceuticals, Incorporated	- USD	Infinity%
Institute of Biomedical Research Corp.	-0.05 USD	76.699%
SQZ Biotechnologies Company	-2.76 USD	99.565%
Intellipharmaceutics International Inc.	-0.09 USD	86.27%
Propanc Biopharma, Inc.	-0.02 USD	49.367%
Mesoblast Limited	-0.09 USD	86.532%
Marizyme, Inc.	-1.44 USD	99.167%
Genus plc	0.12 USD	110.0%
VioQuest Pharmaceuticals, Inc.	-2.33 USD	99.485%
Pharming Group N.V.	-0.02 USD	25.466%
Therapeutic Solutions International, Inc.	-0.00 USD	-1614.286%
CNBX Pharmaceuticals Inc.	-0.42 USD	97.143%
Nymox Pharmaceutical Corporation	-0.10 USD	87.565%
ContraFect Corporation	-124.97 USD	99.99%
PsyBio Therapeutics Corp.	-0.04 USD	71.429%
Sienna Biopharmaceuticals, Inc.	- USD	Infinity%
IMV Inc.	-4.37 USD	99.725%
AXIM Biotechnologies, Inc.	-0.04 USD	66.102%
MultiCell Technologies, Inc.	-0.00 USD	-11900.0%
ONE Bio Corp.	1.43 USD	100.839%
Accustem Sciences Inc.	-0.34 USD	96.471%
RVL Pharmaceuticals plc	-0.58 USD	97.931%
Arno Therapeutics, Inc.	- USD	Infinity%
EV Biologics, Inc.	-0.12 USD	90.0%
Q BioMed Inc.	-0.08 USD	84.635%
Emmaus Life Sciences, Inc.	-0.07 USD	82.93%
Mosaic ImmunoEngineering Inc.	-0.33 USD	96.364%
Biomind Labs Inc.	-0.02 USD	25.926%
American Oriental Bioengineering, Inc.	-781.24 USD	99.998%
Provectus Biopharmaceuticals, Inc.	-0.01 USD	-62.162%
TetraLogic Pharmaceuticals Corporation	- USD	Infinity%
Oncotelic Therapeutics, Inc.	-0.02 USD	39.698%
GlobeStar Therapeutics Corporation	-0.00 USD	-400.0%
THC Farmaceuticals, Inc.	-0.00 USD	-1400.0%
Curative Biotechnology, Inc.	-0.01 USD	-36.364%
GB Sciences, Inc.	-0.00 USD	-192.683%
Alpha Cognition Inc.	-0.15 USD	92.0%
HST Global, Inc.	-0.03 USD	56.989%
CSL Limited	2.73 USD	100.44%
Wesana Health Holdings Inc.	-0.05 USD	76.048%
Halberd Corporation	-0.00 USD	-11900.0%
Enzolytics Inc.	-0.00 USD	-1614.286%
Agentix Corp.	-0.04 USD	65.714%
Resverlogix Corp.	-0.01 USD	15.493%
Nuo Therapeutics, Inc.	-0.08 USD	84.085%
MetaStat, Inc.	- USD	Infinity%
argenx SE	-5.16 USD	99.767%
Enzon Pharmaceuticals, Inc.	0.00 USD	1023.077%
Endonovo Therapeutics, Inc.	0.03 USD	147.809%
RespireRx Pharmaceuticals Inc.	-0.04 USD	66.387%
GeneThera, Inc.	- USD	Infinity%
Inhibitor Therapeutics, Inc.	-0.02 USD	40.0%
AVAX Technologies, Inc.	-0.05 USD	77.737%
Zenith Capital Corp.	-0.07 USD	82.833%
Genscript Biotech Corporation	-0.05 USD	73.568%
Ember Therapeutics, Inc.	-0.01 USD	-90.476%
Anthera Pharmaceuticals, Inc.	- USD	Infinity%
Sigyn Therapeutics, Inc.	-3.77 USD	99.682%
WPD Pharmaceuticals Inc.	-0.00 USD	-2300.0%
Cotinga Pharmaceuticals Inc.	-0.09 USD	86.857%
Kadimastem Ltd	-0.78 USD	98.462%
Helix BioMedix, Inc.	-4.70 USD	99.745%
VitaSpring Biomedical Co. Ltd.	- USD	Infinity%
Capstone Therapeutics Corp.	-36.39 USD	99.967%
BioStem Technologies, Inc.	-0.62 USD	98.065%
Oncology Pharma Inc.	- USD	Infinity%
Reve Technologies, Inc.	-0.01 USD	-0.84%
LadRx Corporation	0.68 USD	101.765%
Cell Source, Inc.	-0.17 USD	92.941%
Regen BioPharma, Inc.	0.29 USD	104.138%
Regen BioPharma, Inc.	0.26 USD	104.615%
NovAccess Global Inc.	-0.23 USD	94.783%
Affymax, Inc.	-0.39 USD	96.923%
Itoco Inc.	-0.01 USD	-57.895%
Rasna Therapeutics, Inc.	-0.01 USD	-20.0%
Pathfinder Cell Therapy, Inc.	-0.00 USD	-380.0%
Mobile Lads Corp.	-0.01 USD	-114.286%
CytoDyn Inc.	-0.05 USD	77.316%
Claritas Pharmaceuticals, Inc.	- USD	Infinity%
NDT Pharmaceuticals Inc.	-0.00 USD	-2300.0%
NanoSphere Health Sciences Inc.	-0.02 USD	45.946%
Alseres Pharmaceuticals, Inc.	-153.67 USD	99.992%
SYBLEU INC	-0.02 USD	31.429%
Advanced Proteome Therapeutics Corporation	- USD	Infinity%
ImmunoCellular Therapeutics, Ltd.	-0.01 USD	15.493%
International Stem Cell Corporation	-0.02 USD	26.829%
Bioxytran, Inc.	-0.03 USD	62.382%
GlobeImmune, Inc.	- USD	Infinity%
Predictive Technology Group, Inc.	- USD	Infinity%
ProText Mobility, Inc.	- USD	Infinity%
Cardax, Inc.	- USD	Infinity%
VG Life Sciences Inc.	-0.00 USD	-11900.0%
Kaleido Biosciences, Inc.	- USD	Infinity%
Advaxis, Inc.	-7.99 USD	99.85%
Adhera Therapeutics, Inc.	-1.18 USD	98.983%
RenovaCare, Inc.	- USD	Infinity%
Regnum Corp.	-0.03 USD	64.706%
Innovation Pharmaceuticals Inc.	-0.01 USD	-90.476%
Neutra Corp.	-0.00 USD	-11900.0%
Windtree Therapeutics, Inc.	-94.23 USD	99.987%
PureTech Health plc	-2.38 USD	99.496%
Coeptis Therapeutics, Inc.	-0.83 USD	98.554%
IXICO plc	-0.02 USD	50.82%
IntelGenx Technologies Corp.	-0.06 USD	78.873%
Gelesis Holdings, Inc.	-1.35 USD	99.111%
CSL Limited	5.47 USD	100.219%
Cellectis S.A.	-1.77 USD	99.322%

Global Stocks Search

RegeneRx Biopharmaceuticals, Inc. (RGRX)

Eps Summary of RegeneRx Biopharmaceuticals, Inc.

Annual Eps Chart of RegeneRx Biopharmaceuticals, Inc. (2022 - 1995)

Historical Annual Eps of RegeneRx Biopharmaceuticals, Inc. (2022 - 1995)

Peer Eps Comparison of RegeneRx Biopharmaceuticals, Inc.